FromBraeburn News ([email protected])
Subject (20)Braeburn News Update
Preheader (150)View this email in your browser FDA Accepts Braeburn’s New Drug Application Resubmission for BRIXADI™ (buprenorphine) Extended-Release Subcutaneous In
Helvetica
Text Analysis
Body Words991
Subject Words3
Body Emojis2
Subject Emojis
Media Analysis
Text Links6
Image Links4
Total Links10
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px1680 px
X-Spam Score-5.9
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeEarly Morning
